Clinical trials have demonstrated that semaglutide produces substantial weight loss when combined with lifestyle modifications including reduced caloric intake and increased physical activity
IGF-1 DES, also known as insulin-like growth factor 1 DES , is a truncated version (splice variant) of IGF-1, a hormone produced by the human liver
When looking specifically at the use of semaglutide and liraglutide in the subgroup analyses, researchers only analyzed the data from the three-month and six-month follow-ups
*indicates specific protein bands identified by CBB staining
Neuritin significantly upregulated the expression of microtubule-associated protein 2 (Map2), neuronal nuclei (NeuN), and postsynaptic density protein 95 (PSD95) in the hippocampus of Amyloid precursor protein (APP)/Presenilin 1 (PS1) transgenic AD mice
The SUSTAIN-6 trial showed cardiovascular benefit, which expanded the label in 2020